Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
前收盤價
US$277.33
+US$0.36 · +0.13%
盤中時間採用ET。市場資料可能有所延遲。
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
日內區間
目前US$277.33
52週區間
目前US$277.33
盤中時間採用ET。市場資料可能有所延遲。
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
日內區間
目前US$277.33
52週區間
目前US$277.33
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 251.16億 USD | 225.95億 USD | 204.98億 USD | 184.49億 USD | 171.08億 USD |
| 銷貨成本 | 90.51億 USD | 80.5億 USD | 80.04億 USD | 74.09億 USD | 63.99億 USD |
| 毛利 | 160.65億 USD | 145.45億 USD | 124.94億 USD | 110.4億 USD | 107.09億 USD |
| 研究與開發 | 15.82億 USD | 14.66億 USD | 12.93億 USD | 12.3億 USD | 11.33億 USD |
| 銷售、一般及管理費用 | 86.51億 USD | 75.03億 USD | 69.2億 USD | 60.76億 USD | 58.13億 USD |
| 營業費用 | 111.76億 USD | 108.56億 USD | 82.13億 USD | 73.06億 USD | 69.46億 USD |
| 利息收入 | 1.21億 USD | 1.39億 USD | 7500萬 USD | 9400萬 USD | 6800萬 USD |
| 利息支出 | 6.07億 USD | 3.96億 USD | 3.56億 USD | 3.37億 USD | 3.37億 USD |
| 折舊和攤銷 | 11.93億 USD | 10.5億 USD | 10.28億 USD | 9.98億 USD | 9.9億 USD |
| 營業利益 | 48.89億 USD | 36.89億 USD | 42.81億 USD | 37.34億 USD | 37.63億 USD |
| 淨利 | 32.46億 USD | 29.93億 USD | 31.65億 USD | 23.58億 USD | 19.94億 USD |
公司資料更新於 2026年10月11日。
第三方分析師預期可能變動,並非 GoAI 建議。
年度分割調整後的每股現金分配。
US$3.40
2025年(完整年度)+31.5% 自從 2021
2026年(部分年度):US$2.64
US$2.585
2,021
US$2.835
2,022
US$3.05
2,023
US$3.24
2,024
US$3.40
2,025
US$2.64
2,026*
* 在現有股息歷史記錄中,該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年9月30日 | US$0.88Quarterly | 2026年9月30日 | 2026年10月30日 |
股息 | 2026年6月30日 | US$0.88Quarterly | 2026年6月30日 | 2026年7月31日 |
股息 | 2026年3月31日 | US$0.88Quarterly | 2026年3月31日 | 2026年4月30日 |
股息 | 2025年12月31日 | US$0.88Quarterly | 2025年12月31日 | 2026年1月30日 |
股息 | 2025年9月30日 | US$0.84Quarterly | 2025年9月30日 | 2025年10月31日 |
股息 | 2025年6月30日 | US$0.84Quarterly | 2025年6月30日 | 2025年7月31日 |
除息 2026年9月30日
US$0.88
Quarterly
2026年9月30日登記 · 支付日 2026年10月30日
除息 2026年6月30日
US$0.88
Quarterly
2026年6月30日登記 · 支付日 2026年7月31日
除息 2026年3月31日
US$0.88
Quarterly
2026年3月31日登記 · 支付日 2026年4月30日
除息 2025年12月31日
US$0.88
Quarterly
2025年12月31日登記 · 支付日 2026年1月30日
除息 2025年9月30日
US$0.84
Quarterly
2025年9月30日登記 · 支付日 2025年10月31日
除息 2025年6月30日
US$0.84
Quarterly
2025年6月30日登記 · 支付日 2025年7月31日
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T1868.12億0.14%129.35兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI35.51億0.15%2.3兆 USD0.03%US$381.94+0.63%
Vanguard S&P 500 ETFVOO29.68億0.17%1.8兆 USD0.03%US$715.59+0.61%
iShares Core S&P 500 ETFIVV12.85億0.14%8964.4億 USD0.03%US$781.97+0.60%
State Street SPDR S&P 500 ETFSPY11.8億0.14%8172億 USD0.09%US$778.57+0.60%
State Street Health Care Select Sector SPDR ETFXLV6.88億1.58%435.37億 USD0.08%US$170.81+1.58%
Vanguard Morningstar Growth ETFVUG6.47億0.17%3846億 USD0.03%US$91.97+0.72%
Vanguard Dividend Appreciation ETFVIG6.32億0.48%1324億 USD0.04%US$239.05+0.70%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Morningstar Growth ETFVUG
Vanguard Dividend Appreciation ETFVIGAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。